Daniela Dinulescu

Daniela Dinulescu is a highly accomplished researcher in cancer genetics and immuno-oncology, with extensive experience spanning over two decades. At Harvard Medical School, Daniela served as Principal Scientist and Instructor from 2006 to 2010, where notable achievements included the discovery of key precursors for GYN malignancies and the establishment of a genetic link between endometriosis and ovarian cancer. Subsequent roles included Principal Scientist and Investigator at Brigham and Women's Hospital from 2006 to 2023, and Assistant and Associate Professor at Harvard Medical School, contributing to significant advancements in understanding high-grade serous ovarian cancer and developing predictive biomarkers for immuno-oncology trials. Currently, Daniela holds the position of Director at AstraZeneca's Tumor Immunobiology group, leading innovative clinical discoveries. Daniela completed a PhD in Cell and Developmental Biology at Oregon Health & Science University and has pursued additional training in project management and leadership through esteemed programs.